Hamid Sayar

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Placebo Controlled

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

American journal of hematology

Case reports in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology (2023)
Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology (2023)
Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology 98 (4) (2023)
Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology 98 (4) (2023)
Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology (2023)
Andrew H Wei, Hartmut Döhner, Hamid Sayar, Farhad Ravandi, Pau Montesinos, Hervé Dombret, Dominik Selleslag, Kimmo Porkka, Jun-Ho Jang, Barry Skikne, C L Beach, Thomas Prebet, George Zhang, Alberto Risueño, Manuel Ugidos, Wendy L See, Daniel Menezes, Gail J Roboz
Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial. American journal of hematology 98 (4) (2023)
Ryan H Nguyen, Hamid Sayar
Primary Myeloid Sarcoma of the Prostate: A Case Report and Literature Review. Case reports in hematology 2018 (2018)